1. To assess whether acute TRPV1 activation by capsaicin or ENaC down regulation by flavonoids modulate osmoregulation in healthy subjects2. To assess whether capsaicin and flavonoids affect blood pressure
ID
Source
Brief title
Condition
- Cardiac disorders, signs and symptoms NEC
- Electrolyte and fluid balance conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint is the control period-subtracted change in serum sodium
induced after an oral administration of capsaicin or tea, with and without WL.
Secondary outcome
Secondary endpoints hold plasma osmolality, co-peptin, vasopressin (AVP), RAAS
hormones as well as urinary volume, urinary sodium excretion, and urinary
osmolality. Also, blood pressure, body weight and body temperature will be
measured.
Background summary
Hyponatremia, defined as a plasma sodium concentration <135 mmol/L, is the most
common electrolyte disorder found worldwide. Hyponatremia is independently
associated with increased morbidity and mortality in various groups of patients
and in the general population. Attention deficits, gait disturbances, falls,
fractures and osteoporosis are all important consequences of chronic
hyponatremia. Thus, disturbed osmoregulation leading to hyponatremia has
important impact on general health. The pathophysiology of hyponatremia however
is incomplete. Generally, excess of water is regarded as the main cause of a
low serum sodium concentration. Central and local compensation mechanisms
become more active when a change of sodium concentration or plasma osmolality
is detected. The reason why some subjects, despite these compensation
mechanisms, still develop hyponatremia is largely unknown. Our group just
discovered a significant association between plasma sodium concentration and
synonymous single nucleotide polymorphism (SNP) in the TRPV1 gene. TRPV1 is a
protein that can be activated by its ligand capsaicin (i.e., the active purgent
of red hot chili). Modulation of TRPV1 expression and activation by capsaicin
administration is hypothesized to induce hyponatremia. Flavonoids include a
huge group of naturally occurring organic compounds and seem to exhibit effects
on sodium and water homeostasis as well. Animal studies have demonstrated that
flavonoids down regulating the epithelium sodium channel (ENaC) in the kidney,
preventing sodium reabsorption and stimulating natriuresis as a consequence.
Consumption of flavonoids may put subjects at risk of development of
hyponatremia. To our knowledge, the effects of both capsaicin and tea on
hydration status have not been studied in human subjects so far.
Study objective
1. To assess whether acute TRPV1 activation by capsaicin or ENaC down
regulation by flavonoids modulate osmoregulation in healthy subjects
2. To assess whether capsaicin and flavonoids affect blood pressure
Study design
A single-blinded randomized cross-over interventional study
Intervention
Capsaicin and tea (flavonoids) will be administered to examine the effects on
osmoregulation, kidney function and blood pressure with and without a
concurrent water load (WL). For the WL, 20mL/kg water has to be ingested in 20
minutes. For the WL warmish water will be used.
Study burden and risks
Nature and extent of the burden and risk associated with participation, benefit
and group relatedness: When our hypotheses will be confirmed by this study,
further knowledge about the relation between capsaicin, activated TRPV1,
flavonoids, ENaC downregulation, disturbed osmoregulation and sodium
concentration in humans will be provided. Better understanding of
pathophysiological mechanisms in vivo are necessary in order to provide support
for new therapeutic strategies and epidemiological approaches. Participating in
this research project will not lead to personal benefit or to group level
benefit. Little to no burden is expected when participating in this study.
Subjects will visit our research department 4 times, totaling 19 hours. During
these visits venous blood will be drawn totaling approximately 158 mL. Subjects
will be asked to collect 24-h urine thrice. This study aims to unravel one of
the pathophysiological mechanisms leading to hyponatremia. At the very long run
various groups of patients might benefit from the results, particularly
patients at risk for hyponatremia, such as elderly subjects, subjects using
diuretics, subjects with heart failure or renal failure.
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
- Male between 18 and 40 years of age
- Healthy as determined by a responsible and experienced physician, based on a medical evaluation, including medical history, physical examination (PE) and laboratory tests carried out in the screening visit.
- Non-treated office blood pressure *135/85 mmHg
- Body Mass Index (BMI) * 30kg/m2
- Capable of giving written informed consent and able to comply with the requirements and restrictions listed in the
informed consent form.
Exclusion criteria
* An office blood pressure * 135/85 mmHg
* A body mass index * 30 kg/m2
* unwillingness to quit temporally being exposed to spicy food
* A major illness in the past 3 months or any significant chronic medical illness that the investigator would deem
unfavourable for enrolment, including chronic inflammatory diseases.
* A history of any type of malignancy within the past 5 years with the exception of succesfully treated basal cell
carcinoma of the skin.
* A history of any renal disease
* A history of any blood clotting disorders
* A history of any auto-immune disease
* A history of cardiovascular disease (in the past 6 months) defined as documented coronary artery disease
including myocardial infarction (MI), (un-)stable angina pectoris or acute coronary syndrome (ACS), precutenaous
transluminal coronary angioplasty (PTCA), coronary artery bypass grafting (CABG), cerebrovascular disease,
including ischaemic and hemorrhagic stroke or a subarachnoidal bleeding (SAB), or peripheral artery disease,
including aortic aneurysmata (AA).
* A history, within three years, of drugs abuse, including benzodiazepines, opioids, amphetamines, cocain and
Cannabis (THC).
* A history of alcoholism and/or drinking more than 3 units of alcohol per day. Alcoholism is defined as an average
weekly intake > 21 units for males. One unit is equivalent to 8 g Of alcohol: a half-pint (240mL of beer), 1 glass
(125mL) of wine or one measure (25mL) of hard liquor.
* Smoking or usage of tabacco products less than 30 days ago.
* Any other issue that in opinion of the investigator could be harmful to the subject or comprise interpretation of data.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL48629.018.14 |